In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...

Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shares of Novavax Inc. NVAX slid 3.31% to $8.77 Tuesday, on what proved to be an all-around poor trading session for the ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said he is ‘not a fan' of Novavax, Inc. NVAX. On Dec. 4, Novavax agreed ...

Vernon Bernardino, an analyst from H.C. Wainwright, maintained the Buy rating on Novavax (NVAX – Research Report). The associated price target ...

Novavax Inc. closed $15.04 short of its 52-week high ($23.86), which the company reached on June 6th.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at Zacks Research dropped their FY2024 earnings ...